GE HealthCare, RadNet Collaborate to Accelerate AI Adoption

GE HealthCare and DeepHealth, Inc., a wholly-owned subsidiary of RadNet, Inc., announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping increase the efficiency of imaging interpretation and reporting, enabling collaboration across care teams, improving operational workflows.

With the global cancer burden continuing to rise, health systems face increasing challenges and seek solutions to enhance early detection and diagnosis when treatment can be most effective. To help address the global cancer burden and demonstrate the promise of this strategic relationship, the two companies will first work to bring together DeepHealth’s AI-based SmartMammo workflow and clinical solution and GE HealthCare’s patient-centric Senographe Pristina mammography system to bring AI-powered clinical imaging support to breast cancer screening.

GE HealthCare’s Senographe Pristina mammography system was designed to ease anxiety the moment the patient enters the exam room. It features an inviting gantry with elegant lighting and rounded shapes, as well as a soft-curved surface that welcomes patients into a space of comfort and support – with 83% of patients rating their experience with Senographe Pristina better and more comfortable than previous exams.

RadNet’s DeepHealth SmartMammo is an AI-powered SaaS solution designed to seamlessly integrate into existing breast cancer diagnostic workflows, enhancing diagnostic accuracy4 and workflow efficiency. By embedding imaging informatics into advanced mammography systems, the solution can support high-volume breast cancer screening programs. The SmartMammo offering will work to prioritize cases based on suspicion level and ensure seamless integration and interoperability with existing healthcare IT infrastructure.

SmartMammo includes: 1) a cloud-native smart enterprise image viewer with PACS functionality that enables fast image loading and real-time data rendering of multimodality images, accessible from any workstation and location, 2) integration with the radiologist worklist and reporting tools to streamline the workflow, and 3) a suite of clinical AI detection tools that offers automatic lesion localization and degree of suspicion that are effective in diverse populations and dense breast tissue. The cloud-native architecture of the DeepHealth OS powering SmartMammo simplifies support and maintenance while allowing for seamless feature updates and functionality enhancements without any downtime.

Through this collaboration, the two companies also seek to include Smart Alerts, a DeepHealth workflow solution to be integrated with Senographe Pristina that will utilize rapid AI processing with the goal of alerting imaging sites to cases with potentially suspicious lesions in minutes. This kind of solution aims to empower same-day diagnostic exams, follow-up compliance, and reduced anxiety for women with potentially suspicious findings.